Zoetis Inc.: A Global Leader in Animal Health

Zoetis Inc. stands out as a formidable entity in the animal health sector, recognized for its extensive involvement in the discovery, development, manufacture, and marketing of veterinary vaccines and medicines. The company is headquartered in Parsippany, New Jersey, USA, and boasts operations in more than 100 countries worldwide.

Location and Facilities

Strategically dispersed across the globe, Zoetis' facilities include major research centers in the United States and significant production sites in Belgium and Brazil. Noteworthy among these is the Kalamazoo, Michigan facility, which is pivotal in producing Dectomax-CA1, a crucial product aimed at enhancing livestock health.

Financial Indicators

In 2022, Zoetis reported impressive financial metrics, with revenues reaching around $8.1 billion. The company's substantial market capitalization of approximately $80 billion reflects its robust market presence and the confidence it inspires among investors.

Important Company Events

A recent landmark event for Zoetis is the conditional approval of its avian influenza vaccine by the U.S. Department of Agriculture. This vaccine plays a crucial role in protecting poultry from the avian flu virus, a significant concern for poultry farmers and agricultural stability. This development highlights Zoetis' commitment to innovation and addressing emerging diseases in animal health.

Company Plans

Zoetis is poised to expand its product portfolio and fortify its standing in the veterinary vaccine market. The company is channeling investments into research and development to discover new solutions addressing global animal health challenges. A key focus is on expanding their vaccine offerings to combat various livestock diseases.

Additionally, Zoetis is advancing in the field of genetic partnerships, as exemplified by its collaboration with McCarty Family Farms and UNIFORM-Agri. These partnerships aim to enhance decision-making for dairy producers through genetic insights and herd management software, underscoring Zoetis' commitment to advancing the dairy industry.

Furthermore, Zoetis is actively involved in the dairy sector through the sponsorship of Dectomax CA-1, a drug approved for various types of dairy cattle, including lactating and dry cows, as well as replacement heifers aged 20 months and older. The company also supports the development of on-farm resources for U.S. dairy farmers by sponsoring manuals and pocket guides.

Eduardo Oliveira is a notable figure within Zoetis, serving as a director on the board of the Dairy Cattle Reproduction Council (DCRC), contributing to the company's influence in the dairy sector.

Modified: 2026/11/20


Milkypedia is a digital project by the international publishing house Dairynews.today, serving as an encyclopedia of the global dairy industry.

It is a living, organic, and comprehensive database of the industry, accessible to everyone online.

Milkypedia by Dairynews.today compiles data on countries and key regions involved in milk production, as well as on companies and prominent figures working in the dairy sector.

Milkypedia by Dairynews.today is an automated system created by the publishing house's developers and Artificial Intelligence. The dairy industry encyclopedia independently updates data on each element. The source and database for Milkypedia are derived from the information published on the Dairynews.today news agency website.

Feedback for developers: ads@dairynews.today